Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The team from Washington University School of Medicine, St. Louis, has warned that people who have undergone bariatric surgery may be at the risk of getting drunk faster as the procedure drastically lowers body tolerance for alcohol. The paper is appeared in the journal JAMA Surgery.

  • Taro Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Keveyis™ (dichlorphenamide) 50 mg Tablets for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis.[1] Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.[2]

  • A new smartphone app that monitors patients suffering from chronic cardiopulmonary diseases by analysing the way they walk can warn doctors at the first sign of trouble. Using the health-tracking app, MoveSense, developed by researchers at the University of Illinois at Urbana-Champaign, a patient's oxygen saturation level can be passively monitored with medical accuracy. Oxygen saturation is a standard measure of health status.

    • Certificate of Merit for an initiative for knowledge dissemination & training in the area of good manufacturing practices (GMP) By Dr. R. P. Singh (Secretary general, QCI) and Mr. Hari K. Taneja (Trustee, D.L.Shah Trust) in 10th National Quality Conclave held on August 7-8, 2015 at Sirifort Auditorium, New Delhi.

    The Annual Flagship event of QCI, the 10th National Quality Conclave “Creating an Ecosystem for World Class Quality in India” with World Health Organization (as Technical Partner for Health Thematic Session) and ASQ (as the Knowledge Partner) held on August 7-8, 2015 in New Delhi. The Quality Conclave 2015 is a platform to know what the world has done and how India can build an Ecosystem of Quality in every sphere of life.

    [adsense:336x280:8701650588]

  • A new study has revealed that even moderate levels of stress can impair self-control. The scientists found that when individuals chose between different food options after having experienced the stressful ice bath treatment, they were more likely to choose an unhealthy food. The study published in the journal Neuron.

  • Hetero Group, one of India’s leading generic pharmaceutical companies  has recently announced the launch of its biosimilar ‘Rituximab’ under the brand name Maball in India. It will be marketed and distributed by Hetero Healthcare Limited, a group company of Hetero. Rituximab is recommended as the first-line treatment for NHL and is available in a single dose vial with two strengths – 100mg/10ml and 500mg/50ml.

Subscribe to Pharma News